Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
BrainChip Holdings ( (AU:BRN) ) has provided an announcement.
BrainChip’s December 2025 quarter was marked by steady early-stage commercial traction and a strengthened balance sheet as it pushes to scale its neuromorphic AI platform. Customer cash inflows rose slightly to US$0.4 million while operating outflows fell to US$4.3 million, and the company bolstered liquidity to US$31.7 million following a fully underwritten A$35 million institutional placement and an oversubscribed share purchase plan, positioning it to fund commercialisation of its Akida technology and next-generation edge AI products. Operationally, BrainChip advanced a strategic multi-year partnership with Parsons’ Blue Ridge Envisioneering, including an initial 10,000-chip order and a supply framework geared to high-volume defence deployments, and it commenced volume production of its AKD1500 edge AI co-processor, which has been designed into solutions for defence and medical sensing and received a further order from Nex Novus. The AKD1500’s ultra-low power performance, compatibility with x86, ARM and RISC-V systems, and support for on-chip learning via BrainChip’s MetaTF toolchain and Akida architecture reinforce the company’s bid to capture share in the growing edge AI market, supported by an expanding portfolio of 61 issued and pending patents that enhances its competitive positioning.
The most recent analyst rating on (AU:BRN) stock is a Hold with a A$0.17 price target. To see the full list of analyst forecasts on BrainChip Holdings stock, see the AU:BRN Stock Forecast page.
More about BrainChip Holdings
BrainChip Holdings Ltd is a semiconductor company specialising in neuromorphic artificial intelligence, positioning itself as the world’s first commercial producer of this technology. Its primary products include the Akida neuromorphic processors and the AKD1500 edge AI accelerator co-processor, which target low-power, real-time AI inference and on-device learning for defence, industrial, healthcare, wearables, consumer electronics and broader edge AI applications across the United States, Europe and the APAC region.
Average Trading Volume: 8,489,560
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$390.4M
For an in-depth examination of BRN stock, go to TipRanks’ Overview page.